Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans · New York Stock Exchange
InsiderStreet
EQUITY FACTSHEET
Generated: 2026-Oct-18 · Market data through: 2026-10-16
Last Close
$69.16
2026-10-16
Market Cap
$34.2B
Volume
3.3M
52-Wk High
$71.21
52-Wk Low
$31.63
Trailing PE
-6.7
P/S
0.18
Gross Margin
16.1%
Net Margin
-2.6%
ROE
-24%
ROIC
-13%
Piotroski
6/9
Altman Z
2.8
1-Yr Return
+94.0%
5-Yr Return
+48.6%
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
SectorHealthcareIndustryMedical - Healthcare PlansExchangeNYSEMarket Cap$34.2BEmployees61,100 (SEC-filed)CEOSarah McGinty LondonIPO2001-12-13CountryUS
Centene Plaza, St. Louis, MO 63105  ·  Tel 314 725 4477  ·  centene.com
INSIDERSTREET SCORE37 / 100Street mean $75.57 (7 analysts, last qtr) — their number, not ours
INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$12M sold / 6 mo, zero open-market buys
1 Year vs S&P 500 · CNC +94.0% · S&P 500 +15.9% · spread +78.2pp
88127165204Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26CNCS&P 500
7 Years vs S&P 500 · CNC +48.6% · S&P 500 +189.9% · spread -141.3pp
441312193072019202020212023202420252026CNCS&P 500
Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
INSIDERSTREET
SCORE
37of 100

Score Breakdown

Profitability7/100
Growth39/100
Momentum40/100
Quality45/100
Earnings Quality38/100
Balance Sheet44/100
Value40/100
Risk (safety)65/100
Overall36.8/100
Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

SymbolIS Score
HUM
27
CI
61
ELV
57
MOH
30
CVS
52
OSCR
76
CNC
37

IS Score Trend — quarterly

3040506123 Q123 Q324 Q124 Q325 Q125 Q326 Q1
14 quarters, 23 Q1 to 26 Q2. Peak 59 in 23 Q2, latest 37 — -22 since. Dropped below the 40 line in 25 Q2, at 34. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.
BUSINESS QUALITY37 / 100IS Score 36.8 / 100 · -22.3 from peak of 59
3040506123 Q123 Q424 Q325 Q226 Q1
Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.
PRICE STRUCTUREBULLISHTechnical Score 82 / 100 · Power +64 · 20 of 22 indicator votes bullish
13%44%74%105%07-2308-1309-0309-2510-16
Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

These two disagree — business quality 37, price structure 82 out of 100, so the price reads better than the business does. We publish the disagreement rather than resolving it: they answer different questions, and the gap between them is information, not an error.

TriggerWhere it stands nowWhat it would mean
IS Score reaches 55 and holds two consecutive quartersnow 36.8would move us up one band
IS Score stops falling - one quarter higher than the priorlast four: 36 → 35 → 39 → 37the direction matters more than the level
Technical vote share back above 50%now 100%price structure no longer broken
Institutional holder count rises two quarters runningpeak 1,004 → now 1,004fewer institutions willing to hold is our clearest warning
We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score2 of 4top 13% of 29,420 symbols
Sources Aligned— of 3independent disclosures
Congress (180d)0 buysnone disclosed
Insider Buys (180d)0none disclosed
ETF Funds (30d)1237 up / 957 downnet +280 funds
Institutions Added (13F)137managers opening or increasing
Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

80987894610152023 Q32024 Q12024 Q32025 Q12025 Q32026 Q1
Peak 1,004 · latest 1,004 (+0 from peak).
QuarterHolders13F sharesValueReported own%
2026 Q21,004490.8M$30.2B99.4%
2026 Q1867474.4M$15.0B96.1%
2025 Q4912476.5M$19.5B96.5%
2025 Q3849459.5M$16.1B93.0%
2025 Q2871480.4M$25.9B97.3%
2025 Q1899486.3M$29.2B98.5%
2024 Q4877481.2M$28.8B97.4%
2024 Q3880494.5M$36.9B100.1%
2024 Q2895521.8M$33.8B105.7%
2024 Q1930518.3M$38.6B105.0%
2023 Q4896511.3M$37.0B103.5%
2023 Q3820507.3M$34.2B102.7%
How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
InsiderRoleDateTypeSharesValuePost-Txn Owned
Carson Michael AGroup President, Medicare&Spec2026-10-15TAX W/H7,130$0.50M115,752
Tyler Lauren Mdirector2026-09-30A-Award482—3,698
Tanji Kennethdirector2026-09-30A-Award603—13,093
Samuels Theodore R. Iidirector2026-09-30A-Award583—25,796
Eppinger Frederick Hdirector2026-09-30A-Award864—370,402
Coughlin Christopher Jdirector2026-09-30A-Award583—19,294
Pienkos Theodore JCorporate Controller & CAO2026-09-15TAX W/H1,092$0.08M28,751
Koster ChristopherSecretary & General Counsel2026-08-26SELL56,500$3.78M248,854
6-mo decomposition (Form 4)TxnsSharesValueSignal weight
S — Open-market sales3184,103$12.1MCounted
F — Tax withholding1079,120$3.0MNone — compensation
P — Open-market purchases00$0Counted — none occurred

Monthly Net Insider Flow (000 shares)

-104K-58K-12K34K+3405-7806+607-10408+209-710
Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal
Open-Market Sells$12.1M3 txns / 6 mo
Open-Market Buys$0.0M0 txns / 6 mo
ClusterNone active3+ insiders / 21 days
FiledFilerShares registeredEst. proceeds
2026-08-26Koster Christopher56,500$3.8M
2026-08-26Burdick Kenneth A43,600$2.8M
2026-08-18Koster Christopher47,603$3.1M
2026-08-05Burdick Kenneth A100,000$6.8M
Trailing 12 mo9 filings409,974$25M
FiledFormReporting person% of classShares
2026-04-29SCHEDULE 13GVanguard Capital Management7.30%35.9M sh
2026-03-26SCHEDULE 13G/AThe Vanguard Group—exit/reporting change
2026-02-13SCHEDULE 13GAQR Capital Management Holdings, LLC6.47%31.8M sh
2025-11-05SCHEDULE 13G/AAbigail P. Johnson0.70%3.3M sh

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
MemberChamberTradeSize bandTradedDisclosed
Ro KhannaHouseSELL$1,001 - $15,0002026-09-042026-10-09
Ro KhannaHouseSELL$15,001 - $50,0002026-08-102026-09-07
Tim MooreHouseSELL$100,001 - $250,0002025-08-182025-09-04
House 12-Mo2 trades0 purchases
Senate 12-Mo0 tradesNone purchases
CoverageSTOCK Act filings30-45 day disclosure lag
13F Filers (last complete Q)867
13F Shares474M96.1% of shares out
New / Closed105 / 135positions, QoQ
Increased / Reduced307 / 348positions, QoQ
Put/Call (13F)0.66option positions
Free Float98.2%485M sh

2.8 · Largest Reporting 13F Managers

ManagerSharesValue
Assenagon Asset Management S.A.4.1M$254M
Ninety One Uk Ltd1.5M$93M
Wealth Enhancement Advisory Servic644,499$38M
Wedge Capital Management L L P/Nc409,069$25M
Fjarde Ap-Fonden /Fourth Swedish N183,004$11M
Counterpoint Mutual Funds Llc145,297$9M
EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

FundWeightPosition
VITSX0.0%$973M
VTSAX0.0%$973M
VSMPX0.0%$973M
VTI0.0%$973M
VOO0.0%$806M
VFFSX0.0%$806M

13F Filers Holding CNC — quarterly

840898955101324Q124Q325Q125Q326Q1

Institutional Put/Call — quarterly

0.600.811.021.2324Q124Q325Q125Q326Q1
15%34%54%74%07-2308-1008-2609-1409-30
Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.
Latest Session51.8%2026-10-15
20-Day Avg42.4%50-day 43.7%
TrendFalling20d vs 50d
By Market CenterQ: 51% · N: 67% · B: 67%latest session

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Weekly Notional ($B)
$0.2B$0.4B$0.6B$0.7B06-1507-0607-2708-17

Where CNC Trades in the Dark

ATS Venue (4-wk)SharesAvg trade
Incr Intelligent Cross Llc6.3M62 sh
Ubsa Ubs Ats5.8M70 sh
Mstx Ms Trajectory Cross (Ats-1)5.0M91 sh
Sgmt Sigma X23.2M71 sh
Ebxl Level Ats3.2M37 sh
Mspl Ms Pool (Ats-4)2.8M192 sh
Medicaid Segment$147.6BCommercial Segment$42.0BOther Operating Segmen$5.1BRevenue$194.8BGross profit$23.8BCost of revenue$170.9BOperating expenses$13.3BNet loss$-6.7B
Where a dollar of Centene Corp. revenue goes. All values FY2025 filings, live.
SwitchingIntangiblesNetworkCost adv.Scale
CNC (live moat model)Peer median: HUM · CI · ELV · MOH · CVS
Component scores from the live moat model. Peer median illustrative.

Moat score 42/100 — Weak; primary source Efficient Scale.

This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

3.8 · Employees (SEC filings)

46K56K66K76K2018202020222024
OfficerTitle
Sarah LondonChief Executive Officer & Director
Keith Harvey WilliamsonPresident of Charitable Foundation
Andrew Lynn AsherExecutive Vice President & Chief Financial Officer
Christopher Andrew KosterExecutive Vice President, General Counsel & Secretary
Revenue ($B)
$0B$65B$131B$196B126FY21145FY22154FY23163FY24195FY25196FY26E193FY27E
EPS ($) — GAAP diluted actual, street-basis estimate
$-13.62$-6.98$-0.33$6.312.28FY212.07FY224.95FY236.31FY24-13.62FY254.87FY26E5.30FY27E
Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.
Quarterly EPS — Actual vs. Consensus
$-1.46$0.37$2.21$4.0425-0425-0725-1026-0226-0426-07NextE
Beats (>2%)5 of 6recent quarters
Avg Surprise+48.9%
Next Report2026-10-27
Income QualityN/Mloss-making — OCF ÷ net income not meaningful

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Beat Rate—%0 of 0 quarters
Current Streak0longest 0
Avg EPS Surprise—%median —%
Surprise Trend—last 4 vs prior 4
PeriodEPS est.EPS actualEPS surpriseRev est. ($M)Rev actual ($M)Rev surprise
Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.
$-8B$60B$127B$195BFY21FY22FY23FY24FY25RevenueGross profitOperating incomeNet income
Profit Margins (%)
-4%1%7%12%11.31.41.1FY2111.50.90.8FY2211.21.91.8FY2310.31.92.0FY2412.2-3.9-3.4FY25GrossOperatingNet
Revenue by Segment — Stacked
$0B$69B$138B$206B$118BFY21$135BFY22$140BFY23$163BFY24$195BFY25Health Care, PServiceMedicaid SegmeCommercial SegOther Operatin
Live segmentation data.
YoY Growth Heatmap — Income Lines
YoY growthFY21FY22FY23FY24FY25
Revenue+13.4%+14.7%+6.5%+5.9%+19.4%
Gross profit-6.7%+17.3%+4.0%-2.8%+41.6%
Operating income-42.1%-26.1%+122.3%+8.4%-339.9%
Net income-25.5%-10.8%+124.8%+22.3%-301.9%

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
$B · FY endsFY21FY22FY23FY24FY25Trend
Revenue126.0144.5154.0163.1194.8
Cost of revenue111.8127.9136.7146.2170.9
Gross profit14.216.717.316.823.8
R&D expense0.00.00.00.00.0
SG&A expense9.611.612.612.413.3
Operating income1.81.32.93.2-7.6
EBITDA3.84.15.66.2-5.1
D&A1.31.41.31.21.3
Pretax income1.82.03.64.3-6.7
Income tax0.50.80.91.0-0.1
Net income1.31.22.73.3-6.7
Diluted EPS ($)2.282.074.956.31-13.62
Diluted shares (M)591582546524491
Operating CF$5B
CapEx$1B
Free cash flow$4B
SBC$0B
Buybacks$0B
Net cash change$4B
Operating cash flow$5.09BFree cash flow$4.32BCapEx$0.77BBuybacks$0.47BRetained cash$3.85B
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$BFY22FY23FY24FY25
Cash & equivalents12.117.214.117.9
ST investments2.32.52.60.0
Receivables (net)13.315.519.718.1
Total current assets30.140.838.036.0
PP&E (net)5.02.42.42.4
Goodwill + intangibles25.723.723.015.4
Total assets76.984.682.477.7
Accounts payable9.316.313.020.5
Short-term debt0.10.10.10.2
Deferred revenue0.50.70.70.7
Total current liabilities28.536.734.321.5
Long-term debt17.917.718.418.0
Total liabilities52.658.755.957.6
Shareholders' equity24.226.026.520.1

Cash Flow Statement — Full

$BFY22FY23FY24FY25
Net income1.22.73.3(6.7)
D&A1.61.31.21.3
Stock-based compensation0.20.20.20.2
Working capital change2.23.4(4.5)0.8
Operating cash flow6.38.10.25.1
Capital expenditures(1.0)(0.8)(0.6)(0.8)
Investing cash flow(2.9)(1.3)(1.1)0.5
Buybacks(3.1)(1.6)(3.1)(0.5)
Dividends paid0.00.00.00.0
Debt issuance / (repay)(1.1)0.00.7(1.1)
Financing cash flow(4.2)(1.6)(2.4)(1.6)
Free cash flow5.37.3(0.5)4.3
Balance Sheet Structure ($B)
$0B$28B$56B$85BFY22FY23FY24FY25Total assetsTotal liabilitiesEquity
Cash Generation vs Capex ($B)
$-0B$2B$5B$8BFY22FY23FY24FY25Operating CFCapexFree cash flow
Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
RatioFY21FY22FY23FY24FY25TTMTrend
PROFITABILITY
ROE5.1%4.7%10.8%12.7%-28.8%-24%
ROA1.8%1.5%3.3%4.0%-8.3%-6.1%
ROIC3.8%2.6%8.8%8.4%-28.9%-12.9%
Gross margin11.3%11.5%11.2%10.3%12.2%16.1%
Operating margin1.4%0.9%1.9%1.9%-3.9%-2.8%
Net margin1.1%0.8%1.8%2.0%-3.4%-2.6%
EBITDA margin3.0%2.8%3.6%3.8%-2.6%-1.4%
FCF margin2.6%3.6%4.7%-0.3%2.2%—
VALUATION
P/E36.2038.2014.779.20-3.03-6.7
P/B1.821.911.541.151.011.5
P/S0.390.320.260.190.100.18
P/FCF14.808.745.50-62.064.683.8
EV/EBITDA14.3612.846.975.35-4.42-9.6
EV/Revenue0.450.370.250.200.110.1
Earnings yield2.8%2.6%6.8%10.9%-33.0%-14.93%
FCF yield6.8%11.4%18.2%-1.6%21.4%26.25%
RatioFY21FY22FY23FY24FY25TTMTrend
LEVERAGE & SOLVENCY
Current ratio1.111.061.111.111.681.15
Quick ratio1.111.061.111.111.681.15
Debt / equity0.850.890.730.740.940.71
Debt / assets28.9%27.8%22.3%23.6%24.2%19.4%
Net debt / EBITDA2.021.69-0.140.44-0.192.95
Interest coverage3.733.955.967.06-8.92—
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
RatioFY21FY22FY23FY24FY25TTMTrend
EFFICIENCY
Asset turnover1.711.861.911.952.432.33
Receivables turnover11.4911.3310.699.2510.3010.7
DSO (days)323234393534
DPO (days)252534373640
Cash conversion cycle77-03-0-6
GROWTH (YoY)
Revenue growth13.4%14.7%6.5%5.9%19.4%—
Net income growth-25.5%-10.8%124.8%22.3%-301.9%—
EPS growth-27.0%-5.7%134.1%31.0%-306.4%—
FCF growth-28.9%59.5%38.0%-106.8%981.8%—
PER SHARE ($)
EPS (diluted, TTM)2.282.155.036.58-13.59-10.33
Book value / share45.2842.9648.0652.6140.6345.88
Revenue / share212.89258.15286.45324.86396.64392.32
FCF / share5.579.3913.49-0.988.8018.16
Cash / share24.7725.7136.5533.2436.4354.79
SHAREHOLDER RETURN & SCORES
Buyback yield0.6%6.7%4.1%10.3%2.4%0.11%
Altman Z-Score2.472.712.652.822.842.8
Piotroski F-Score568566/9
Beneish M-Score-2.37-2.71-2.55-2.03-3.44-3.80
ModelScoreZoneNote
Piotroski F-Score6 / 9Middling
Altman Z-Score2.8Grey zoneGrey
Income qualityN/MLoss-makingOCF ÷ net income not meaningful with negative earnings; OCF itself is the signal
Beneish M-Score-3.80Non-manipulatorvs −2.22 threshold
DuPont Decomposition (TTM)Value
Tax burden1.10
Interest burden1.16
Operating margin-2.1%
Asset turnover2.29×
Financial leverage3.39×
= ROE-20%
Growth Quality (live)Value
Revenue stability0.99
Earnings stability0.25
Earnings persistence0.20
Revenue CAGR 3y9.4%
EPS CAGR 3y—
FCF CAGR 3y5.4%
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Buyback Yield0.11%
Dividend Yield0.00%none paid
Total Shareholder Return-0.01%cash yield
SBC / Revenue0.1%dilution pressure
P/E · now -6.7-10x7x24x42x
P/S · now 0.180.1x0.2x0.3x0.4x
EV/EBITDA · now -9.6-11x-2x7x16x
CompanyMkt capP/EROENet marginRev growthPiotroski1-yr ret
HUM$49.6B38.87%1.7%+18.3%4/9+54.6%
CI$79.9B12.515%2.3%+7.7%8/9+4.5%
ELV$92.9B19.011%2.9%+6.3%6/9+23.6%
MOH$10.8B1296.0-0%0.6%+2.6%5/9+10.0%
CVS$118.1B24.16%2.8%+7.4%8/9—
OSCR$8.3B18.634%7.4%+42.8%7/9—
BIIB$34.4B41.05%3.6%-0.5%3/9—
RMD$33.6B22.924%26.2%+9.9%7/9—
1-yr returns computed from adjusted price history; peers without a tracked series show —.
Buy
44 Analysts
Str Sell (0)Sell (1)Hold (16)Buy (27)Str Buy (0)
Mean Target (qtr)$75.577 targets
Target vs. Price+9.3%last-quarter mean
Next Report2026-10-27street $0.10
Consensus estimatesRevenue meanHigh / LowEPS meanHigh / Low# EPS est.
FY2026$196.21B$199.71B / $194.29B$4.87$5.07 / $4.7812
FY2027$193.05B$196.00B / $189.85B$5.30$6.20 / $4.9512
FY2028$199.43B$208.56B / $187.04B$6.54$7.21 / $6.085

Street Price Target — Trajectory

WindowAvg Targetvs. Price# Targets
Last Quarter$75.57+9.3%7
Last Year$58.95-14.8%39
All Time$68.16-1.4%74
Rolling mean of published targets vs. last close $69.16. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

C+
DCF
5/5
ROE
1/5
ROA
1/5
Debt/Eq
1/5
P/E
1/5
P/B
4/5
Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
CNC +94.0% vs S&P 500 +15.9% — spread +78.2pp
88127165204Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26CNC +94%S&P 500 +16%
Sector — XLV +24.2%
88127165204Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26CNCXLV
Peer Set — indexed to 100
53104155206Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26CNC +94%HUM +55%CI +5%ELV +24%MOH +10%
All series indexed to 100 at the start of the window, adjusted closes.
$28$43$57$7218MVol705030RSI 62Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26▮ up▮ downSMA20SMA50BB(20,2)RSI(14)
Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
$31$45$59$74Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26▮up▮downSMA 20SMA 50SMA 200EMA 9EMA 21·· ST Bull·· ST Bear
Moving AverageValueDistance% DistanceSignal
SMA 20$64.72+4.44+6.86%Above
SMA 50$65.39+3.77+5.77%Above
SMA 200$54.15+15.01+27.72%Above
EMA 9$67.65+1.51+2.23%Above
EMA 21$66.09+3.07+4.65%Above
EMA 50$65.10+4.06+6.24%Above
EMA 200$57.17+11.99+20.97%Above
Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.
TECHNICAL VERDICTBULLISHPower Score +6420 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%100
Momentum 25%82
Volume 20%88
Volatility 10%100
Patterns 15%26
13%44%74%105%07-2308-1309-0309-2510-16
This Week100% bullishof 11 price-based votes
4 Weeks Ago45%+55 pts since
12 Weeks Ago45%+55 pts since
ReadImprovingweek-over-week trajectory

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Price vs SMA 20$64.72
Price vs SMA 50$65.39
Price vs SMA 200$54.15
EMA 9/21 Cross67.7/66.1
SMA 50/200Golden
ADX DirectionADX 17
Supertrend$64
Parabolic SAR$63
SMA Slope0.200
RSI62.4
Stochastic K/D92/94
StochRSI K/D93/98
Williams %R-16
CCI146
TSI vs Signal15.9
CMO24.8
ROC9.78%
OBV SignalAccum
Chaikin MF0.120
MFI67
Force Index2M
Elder Ray Bull4.97
62.4RSI (14)30 oversold · 70 overbought
92.4Stochastic %Kvs %D 94
67.1Money Flowvolume-weighted RSI
17.3ADXtrend strength · <20 weak
16.5Williams %Rinverted scale
LevelValueLevelValue
Pivot / R1 / R2$70.46 / $71.06 / $71.60S1 / S2$69.92 / $69.32
Bollinger (20,2)$58.96 – $70.48SqueezeOff
52-wk range$31.63 – $71.06Off 52-wk high-2.7%
ATR (14)$2.14 (3.1%)Historical vol26.5%
+0.7%Jan60%
-2.3%Feb45%
+0.7%Mar52%
+0.4%Apr50%
+3.9%May60%
-0.1%Jun50%
-1.6%Jul45%
-1.2%Aug40%
+1.3%Sep45%
+4.7%Oct50%
+5.3%Nov70%
+2.4%Dec55%
Sample: 20 years — treat short histories as suggestive, not statistical.
Computed from live weekly pricesCNCS&P 500
Weekly volatility (σ, 1y)6.78%1.83%
Best / worst week (1y)+27.5% / -20.1%—
Max drawdown (5y, monthly)-72.3%—
1-week VaR (95%)-7.5%—
Beta (5y)1.111.00
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
CNC EQUITY WEATHER (LIVE)PARTLY CLOUDY · +24
Trend+43
Momentum+65
Volume+35
Volatility-60
Breadth-30
MARKET REGIME (2026-10-16)NEUTRAL
VIX19.99Normal
Dow TheoryConfirmed Bearish
SPY / QQQ TSI7.2 / 4.7trend strength
Sector Strength46/100breadth average
-0.53-0.03+0.48+0.9802-0203-1604-2706-0807-2008-3110-12
Average sentiment of 341 stories, weekly buckets, −1 to +1.
Overall+24.1+15.0 vs industry
Trend+43.0+4.0 vs industry
Momentum+64.7+8.7 vs industry
Volume+35.2+10.7 vs industry
ReadingCNCMedical - Healthcare Plans
n=28
Healthcare
n=5,272
All US symbols
n=70,435
Overall+24.1+9.1-24.0-20.5
Trend+43.0+39.0-25.6-21.3
Momentum+64.7+56.0-28.5-15.8
Volume+35.2+24.6-25.0-3.8
Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.
ExecutiveTotal compStructure
Michael F. Neidorff Chairman, President and $22.0M88% equity+incentive
Cynthia J. Brinkley Executive Vice President$4.7M84% equity+incentive
Jesse N. Hunter Executive Vice President, Pr$4.4M84% equity+incentive
Jeffrey A. Schwaneke Executive Vice Presiden$4.3M85% equity+incentive
Keith H. Williamson Executive Vice President$3.0M78% equity+incentive

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Pillar (live disclosure scores)Score
Environmental55
Social53
Governance66
Composite ESG58
Composite ESG Trend
5556585920172019202120232025
Filed8-K contentsItems
2026-10-08Other Events8.01
2026-09-16Regulation FD7.01
2026-08-17Officer/Director Change; Regulation FD; Exhibits5.02,7.01,9.01
2026-07-29Other Events8.01
2026-07-28Earnings Release; Officer/Director Change; Regulation FD; Exhibits2.02,5.02,7.01,9.01
2026-06-22Officer/Director Change; Regulation FD; Exhibits5.02,7.01,9.01
2026-05-15Officer/Director Change; Shareholder Vote5.02,5.07
2026-04-28Earnings Release; Exhibits2.02,9.01

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.
This space intentionally left blank — the next section begins on the following page

Centene Corp. (CNC)

Healthcare / Medical - Healthcare Plans
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Data domainSourceCoverage for this report
Price & volumemarket_db.historical_prices52 rows
Fundamentalsincome_statements_annual6 rows · 2020 to 2025
Reported vs consensusfact/earnings_calendar24 rows · 2020-10-27 to 2026-07-28
Analyst estimatesdim/forward_estimates3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)holdings_db.institutional_ownership_summary99 rows · 2001 to 2026
Insider transactions (Form 4)edgar/form412 rows · 2026-06-30 to 2026-10-15
Proposed sales (Form 144)edgar/form1441 record
Beneficial ownership (13D/G)edgar/13dg4 rows · 2025-11-05 to 2026-04-29
Short-sale volume (FINRA)edgar/short_volume_daily60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)edgar/darkpool_weekly12 rows · 2026-06-15 to 2026-08-31
ETF & fund holdingetf_holdings_changelog (30d)1 record
Peer setstock_peers_dynamic8 rows
Industry mediansindustry_medians1 record
Congressional tradescongress_db (House + Senate)1 record
ESGfact/esg_disclosures1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.